Copernicus Therapeutics, Inc.

Biotechnology ResearchUnited States2-10 Employees

Copernicus Therapeutics, Inc. is a clinical stage genomics medicines company whose technology can potentially enable patients with certain genetic disorders to achieve a truly functional cure. Our proprietary, non-viral, nucleic acid delivery  platform, STELLAR,  can carry large payloads and achieves a  robust gene transfer through a receptor-mediated mechanism,  without inducing the immune response that limits  treatment with AAV. Combined with world-class intellectual property in plasmid design for long-term and controlled expression, Copernicus is poised to become a leader in the 21st century in genomic and precision medicine.

Current programs include:

Cystic Fibrosis (Phase I/II Complete)
Eye (Pre-clinical)
Brain (Pre-clinical)

Founded on technologies developed at Case Western Reserve University in Cleveland, Ohio, Copernicus has a strong connection to the growing biotechnology industry in Northeast Ohio.

Sign up for free to view info

Email Format Employee directory